AP

Apontis Pharma AGMUN Apontis Stock Report

Last reporting period 31 Dec, 2022

Updated —

Last price

Market cap $B

0.169

Micro

Exchange

XMUN - Boerse Muenchen

APPH.MU Stock Analysis

AP

Uncovered

Apontis Pharma AG is uncovered by Eyestock quantitative analysis.

Market cap $B

0.169

Dividend yield

Shares outstanding

8.5 B

Website

APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

View Section: Eyestock Rating